Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Wino115on Feb 23, 2021 8:20pm
105 Views
Post# 32643501

RE:RE:RE:SEC filing

RE:RE:RE:SEC filing I am purely guessing, but they are a known healthcare oriented investment fund.  I'm not sure exactly how large as these firms don't have to disclose assets and they usually also have offshore funds for non-US entities and those are totally out of the loop for disclosure.  From what little I can see, they have invested in some other innovative oncology names but also in other healthcare areas -- both private and public.  So definitely specialists in the healthcare area and with some knowledge on innovative therapies.  The full pipeline could be their interest. Perhaps they've met with THTX before or maybe they were a Vertex investor and Leah knew them. Perhaps Dubuc will inform us at some point.   But they are quality, not shady, and as such  adds a bit of "smart-money" credibility to the story. 


realitycheck4u wrote: Nice to have new shareholders on the train with us. Question for those here please. Who is this group? Would any of these people be related in any way to our new or existing Board members in terms of relationships on other boards or funds? Just wondering how They learned of us and wanted to buy so much.


<< Previous
Bullboard Posts
Next >>